Market Research Logo

Infectious Disease Diagnostics Market by Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End User (Hospital, Laboratories) - Global Forecast to 201

Infectious Disease Diagnostics Market by Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End User (Hospital, Laboratories) - Global Forecast to 2019

Increasing Prevalence of Deadly Infectious Disease and Need For Highly Specific and Sensitive Technologies for Rapid Diagnosis to Drive Growth of the IDD Market

The global IDD market report is segmented by product, application, technology, end user, and region. The immunodiagnostics and polymerase chain reaction technology segments accounted for the lion’s share of the global IDD market by technology, owing to growing need for advanced technologies for rapid diagnosis of infectious diseases.

On the basis of application, the IDD market is categorized into the Hepatitis B, Hepatitis C, Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG), human papillomavirus (HPV), methicillin-resistant Staphylococcus aureus (MRSA), and others (Influenza, Ebola, Typhoid, Malaria, and Dengue, among others). Hospital-acquired MRSA infections, human papillomavirus, and AIDS are expected to be new revenue pockets in the applications market. The rising prevalence of these diseases globally is the major factor driving the growth of the aforementioned markets.

On the basis of product, the IDD market is segmented into instruments, consumables (reagents and assays), and software & services. Among products, consumables are estimated to be the fastest-growing market owing to its growing adoption in emerging infectious disease diagnostics worldwide.

On the basis of end user, the market is segmented into hospital laboratories, reference labs, physician’s office labs, academics, and others (blood banks, local public health laboratories, home health agencies, nursing homes, point of care, self-testing). Hospital laboratories are expected to be the fastest-growing market in the forecast period. Owing to the complexity and highly specialized nature of diagnostic tests for infectious diseases, hospital laboratories are expected to grow at the fastest rate in the forecast period, from 2014 to 2019.

From an insight perspective, this report focuses on qualitative data, market size, and the growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis, such as market dynamics (drivers, restraints, opportunities, and threats), winning imperatives, and burning issues. The report also offers market sizes and related growth of various segments in the industry. It focuses on emerging and high-growth segments of the IDD market, high-growth regions, and initiatives of respective governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles offer basic views on key players in the IDD market and their product portfolios, recent developments, and key strategies adopted. The abovementioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, approaches, R&D investments for innovations in products and technologies, and levels of output, in order to remain successful.


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKETS SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • MARKET SIZE ESTIMATION
      • KEY DATA FROM SECONDARY SOURCES
      • KEY DATA FROM PRIMARY SOURCES
      • KEY INDUSTRY INSIGHTS
      • ASSUMPTIONS
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • ATTRACTIVE MARKET OPPORTUNITIES IN INFECTIOUS DISEASE DIAGNOSTICS MARKET
    • INFECTIOUS DISEASE DIAGNOSIS MARKET SNAPSHOT
    • LUCRATIVE GROWTH OPPORTUNITIES IN APAC
    • GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY
    • LIFE CYCLE ANALYSIS, BY REGION
    • INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT
    • IDD MARKET, BY END USER
  • MARKET OVERVIEW
    • INTRODUCTION
      • EVOLUTION
      • MARKET SEGMENTATION
    • MARKET DYNAMICS
      • DRIVERS
        • Table HIGH PREVALENCE RATE OF INFECTIOUS DISEASES AND DEVELOPMENT OF NEW RAPID DIAGNOSTIC TESTS LIKELY TO PROPEL IDD MARKET GROWTH
      • RESTRAINTS
        • Table INCREASING HEALTHCARE COST AND STRINGENT REGULATORY FRAMEWORK ARE RESTRAINING THE GROWTH OF THE IDD MARKET
      • OPPORTUNITIES
        • Table PERSONALIZED MEDICINE IS EXPECTED TO PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES FOR THE IDD MARKET
      • CHALLENGES
        • Table REIMBURSEMENT ISSUES ARE A MAJOR CHALLENGE IN THE IDD MARKET
      • WINNING IMPERATIVE
      • BURNING ISSUE
  • INDUSTRY INSIGHTS
    • INTRODUCTION
    • STRATEGIC BENCHMARKING
    • PEST ANALYSIS
      • POLITICAL FACTORS
      • ECONOMIC FACTORS
      • SOCIO-CULTURAL FACTORS
      • TECHNOLOGICAL FACTORS
    • SUPPLY CHAIN
      • KEY INFLUENCERS
    • INDUSTRY INSIGHTS
  • INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT
    • INTRODUCTION
      • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION)
    • CONSUMABLES
      • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR CONSUMABLES, BY REGION, 2012-2019 ($MILLION)
      • ASSAYS & REAGENTS
        • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR CONSUMABLES, BY COUNTRY, 2012-2019 ($MILLION)
    • INSTRUMENTS & ANALYZERS
      • INTRODUCTION
        • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR INSTRUMENTS & ANALYZERS, BY REGION, 2012-2019 ($MILLION)
      • INSTRUMENTS (OTHER THAN ANALYZERS)
    • ANALYZERS
      • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR INSTRUMENTS & ANALYZERS, BY COUNTRY, 2012-2019 ($MILLION)
    • SERVICES & SOFTWARE
      • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR SERVICES & SOFTWARE, BY REGION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR SERVICES & SOFTWARE, BY COUNTRY, 2012-2019 ($MILLION)
  • GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY APPLICATION
    • INTRODUCTION
      • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
    • HEPATITIS B
      • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR HEPATITIS B, BY REGION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR HEPATITIS B, BY COUNTRY, 2012-2019 ($MILLION)
    • HEPATITIS C
      • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR HEPATITIS C, BY REGION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR HEPATITIS C, BY COUNTRY, 2012-2019 ($MILLION)
    • ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)
      • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR AIDS, BY REGION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR AIDS, BY COUNTRY, 2012-2019 ($MILLION)
    • TUBERCULOSIS (TB)
      • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR TB, BY REGION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR TB, BY COUNTRY, 2012-2019 ($MILLION)
    • CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) INFECTION
      • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR CT/NG INFECTIONS, BY REGION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR CT/NG INFECTIONS, BY COUNTRY, 2012-2019 ($MILLION)
    • HUMAN PAPILLOMAVIRUS (HPV) INFECTION
      • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR HPV INFECTIONS, BY REGION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR HPV INFECTIONS, BY COUNTRY, 2012-2019 ($MILLION)
    • METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) INFECTIONS
      • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR MRSA INFECTIONS, BY REGION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR MRSA INFECTIONS, BY COUNTRY, 2012-2019 ($MILLION)
    • OTHER INFECTIONS
      • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR OTHER INFECTIONS, BY REGION, 2012-2019 ($MILLION)
  • INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY
    • INTRODUCTION
      • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
    • TRADITIONAL DIAGNOSTIC TECHNOLOGIES
      • IMMUNODIAGNOSTICS
        • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR IMMUNODIAGNOSTICS, BY REGION, 2012-2019 ($MILLION)
        • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2012-2019 ($MILLION)
      • BIOCHEMICAL CHARACTERIZATION
        • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR BIOCHEMICAL CHARACTERIZATION, BY REGION, 2012-2019 ($MILLION)
        • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR BIOCHEMICAL CHARACTERIZATION, BY COUNTRY, 2012-2019 ($MILLION)
      • MICROSCOPY
        • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR MICROSCOPY, BY REGION, 2012-2019 ($MILLION)
        • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR MICROSCOPY, BY COUNTRY, 2012-2019 ($MILLION)
    • MOLECULAR DIAGNOSTIC TECHNOLOGIES
      • POLYMERASE CHAIN REACTION (PCR)
        • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR PCR, BY REGION, 2012-2019 ($MILLION)
        • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR PCR, BY COUNTRY, 2012-2019 ($MILLION)
      • ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT)
        • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR INAAT, BY REGION, 2012-2019 ($MILLION)
        • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR INAAT, BY COUNTRY, 2012-2019 ($MILLION)
      • IN SITU HYBRIDIZATION
        • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR IN SITU HYBRIDIZATION, BY REGION, 2012-2019 ($MILLION)
        • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2012-2019 ($MILLION)
      • DNA SEQUENCING & NEXT-GENERATION SEQUENCING (NGS)
        • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR DNA SEQUENCING & NGS, BY REGION, 2012-2019 ($MILLION)
        • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR DNA SEQUENCING & NGS, BY COUNTRY, 2012-2019 ($MILLION)
      • MICROARRAYS
        • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR MICROARRAYS, BY REGION, 2012-2019 ($MILLION)
        • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR MICROARRAYS, BY COUNTRY, 2012-2019 ($MILLION)
      • OTHERS
        • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR OTHER TECHNOLOGIES, BY REGION, 2012-2019 ($MILLION)
        • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR OTHER TECHNOLOGIES, BY COUNTRY, 2012-2019 ($MILLION)
  • INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER
    • INTRODUCTION
      • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
    • HOSPITAL LABORATORIES
      • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR HOSPITAL LABORATORIES, BY REGION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR HOSPITAL LABORATORIES, BY COUNTRY, 2012-2019 ($MILLION)
    • REFERENCE LABORATORIES
      • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES, BY REGION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES, BY COUNTRY, 2012-2019 ($MILLION)
    • PHYSICIANS' OFFICE LABORATORIES
      • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR PHYSICIANS' OFFICE LABORATORIES, BY REGION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR PHYSICIANS' OFFICE LABORATORIES, BY COUNTRY , 2012-2019 ($MILLION)
    • ACADEMIC INSTITUTE LABORATORIES
      • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR ACADEMIC INSTITUTE LABORATORIES, BY REGION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR ACADEMIC INSTITUTE LABORATORIES, BY COUNTRY, 2012-2019 ($MILLION)
    • OTHER END USERS
      • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY REGION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2012-2019 ($MILLION)
  • INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY GEOGRAPHY
    • INTRODUCTION
      • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR TRADITIONAL DIAGNOSTICS, BY TECHNOLOGY, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR MOLECULAR DIAGNOSTICS, BY TECHNOLOGY, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
      • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
      • U.S.
        • Table U.S.: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
        • Table U.S.: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR TRADITIONAL DIAGNOSTICS, BY TECHNOLOGY, 2012-2019 ($MILLION)
        • Table U.S.: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR MOLECULAR DIAGNOSTICS, BY TECHNOLOGY, 2012-2019 ($MILLION)
        • Table U.S.: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION)
        • Table U.S.: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
        • Table U.S.: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
      • CANADA
        • Table CANADA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
        • Table CANADA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR TRADITIONAL DIAGNOSTICS, BY TECHNOLOGY, 2012-2019 ($MILLION)
        • Table CANADA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR MOLECULAR DIAGNOSTICS, BY TECHNOLOGY, 2012-2019 ($MILLION)
        • Table CANADA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION)
        • Table CANADA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
        • Table CANADA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
    • EUROPE
      • Table EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
      • Table EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR TRADITIONAL DIAGNOSTICS, BY TECHNOLOGY, 2012-2019 ($MILLION)
      • Table EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR MOLECULAR DIAGNOSTICS, BY TECHNOLOGY, 2012-2019 ($MILLION)
      • Table EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION)
      • Table EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
      • Table EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
      • GERMANY
      • U.K.
      • REST OF EUROPE (ROE)
    • ASIA-PACIFIC
      • Table ASIA-PACIFIC: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
      • Table ASIA-PACIFIC: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR TRADITIONAL DIAGNOSTICS, BY TECHNOLOGY, 2012-2019 ($MILLION)
      • Table ASIA-PACIFIC: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR MOLECULAR DIAGNOSTICS, BY TECHNOLOGY, 2012-2019 ($MILLION)
      • Table ASIA-PACIFIC: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION)
      • Table ASIA-PACIFIC: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
      • Table ASIA-PACIFIC: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
    • REST OF THE WORLD (ROW)
      • Table ROW: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
      • Table ROW: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR TRADITIONAL DIAGNOSTICS, BY TECHNOLOGY, 2012-2019 ($MILLION)
      • Table ROW: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE FOR MOLECULAR DIAGNOSTICS, BY TECHNOLOGY, 2012-2019 ($MILLION)
      • Table ROW: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION)
      • Table ROW: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
      • Table ROW: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET SHARE ANALYSIS, GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET
    • NEW PRODUCT LAUNCHES
      • Table NEW PRODUCT LAUNCHES, 2011-2014
      • AGREEMENTS & PARTNERSHIPS
        • Table AGREEMENTS, COLLABORATIONS & PARTNERSHIPS, 2011-2014
      • ACQUISITIONS
        • Table ACQUISITION, 2011-2014
      • EXPANSIONS
        • Table EXPANSION, 2011-2014
      • OTHER DEVELOPMENTS
        • Table OTHER DEVELOPMENTS, 2011-2014
  • COMPANY PROFILES
    • INTRODUCTION
    • ABBOTT LABORATORIES
      • BUSINESS OVERVIEW
      • COMPANY SNAPSHOT
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BECTON, DICKINSON & CO.
      • BUSINESS OVERVIEW
      • COMPANY SNAPSHOT
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BIOMÉRIEUX
      • BUSINESS OVERVIEW
      • COMPANY SNAPSHOT
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BIO-RAD LABORATORIES
      • BUSINESS OVERVIEW
      • COMPANY SNAPSHOT
      • PRODUCTS & SERVICES
      • KEY STRATEGY
      • RECENT DEVELOPMENTS
    • ALERE, INC.
      • BUSINESS OVERVIEW
      • COMPANY SNAPSHOT
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • RECENT DEVELOPMENTS
    • THERMO FISHER SCIENTIFIC, INC.
      • BUSINESS OVERVIEW
      • COMPANY SNAPSHOT
      • PRODUCTS AND SERVICES
      • KEY STRATEGY
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • SIEMENS HEALTHCARE
      • BUSINESS OVERVIEW
      • COMPANY SNAPSHOT
      • PRODUCTS & SERVICES
      • KEY STRATEGY
      • RECENT DEVELOPMENTS
    • ROCHE DIAGNOSTICS
      • BUSINESS OVERVIEW
      • COMPANY SNAPSHOT
      • PRODUCT PORTFOLIO
      • KEY STRATEGY
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • DANAHER CORPORATION
      • BUSINESS OVERVIEW
      • COMPANY SNAPSHOT
      • PRODUCTS & SERVICES
      • KEY STRATEGY
      • RECENT DEVELOPMENTS
    • JOHNSON & JOHNSON
      • BUSINESS OVERVIEW
      • COMPANY SNAPSHOT
      • PRODUCTS & SERVICES
      • KEY STRATEGY
      • RECENT DEVELOPMENTS
  • APPENDIX
    • INSIGHTS OF INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report